ATE340577T1 - Mittel gegen posttraumatische stresszustände - Google Patents

Mittel gegen posttraumatische stresszustände

Info

Publication number
ATE340577T1
ATE340577T1 AT02705269T AT02705269T ATE340577T1 AT E340577 T1 ATE340577 T1 AT E340577T1 AT 02705269 T AT02705269 T AT 02705269T AT 02705269 T AT02705269 T AT 02705269T AT E340577 T1 ATE340577 T1 AT E340577T1
Authority
AT
Austria
Prior art keywords
post
traaumatic
remedies
stress conditions
ptsd
Prior art date
Application number
AT02705269T
Other languages
English (en)
Inventor
Shuh Narumiya
Takayuki Maruyama
Original Assignee
Univ Kyoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto filed Critical Univ Kyoto
Application granted granted Critical
Publication of ATE340577T1 publication Critical patent/ATE340577T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Forging (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Saccharide Compounds (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
AT02705269T 2001-03-16 2002-03-15 Mittel gegen posttraumatische stresszustände ATE340577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001075398 2001-03-16

Publications (1)

Publication Number Publication Date
ATE340577T1 true ATE340577T1 (de) 2006-10-15

Family

ID=18932485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705269T ATE340577T1 (de) 2001-03-16 2002-03-15 Mittel gegen posttraumatische stresszustände

Country Status (7)

Country Link
US (2) US20040122100A1 (de)
EP (1) EP1374899B1 (de)
JP (1) JPWO2002076505A1 (de)
AT (1) ATE340577T1 (de)
CA (1) CA2440710C (de)
DE (1) DE60214987T2 (de)
WO (1) WO2002076505A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2009133863A1 (ja) * 2008-04-28 2011-09-01 国立大学法人浜松医科大学 Ｅｐ１アゴニストを含有してなる免疫増強剤
JP6023082B2 (ja) * 2011-01-24 2016-11-09 インセプタム リサーチ アンド セラピューティクス，インク． 精神神経性の疾病を処置するためのプロスタグランジンを含む組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4123568B2 (ja) * 1998-05-06 2008-07-23 小野薬品工業株式会社 ６−オキソ−ｐｇｅ１化合物、それらの製造方法およびそれらを有効成分として含有するプロスタグランジンｅ２受容体作働薬
WO2004082517A2 (en) * 2003-03-19 2004-09-30 Bar Ilan University Animal exhibiting ptsd-like behavior, per pct rule 4.3

Also Published As

Publication number Publication date
EP1374899B1 (de) 2006-09-27
EP1374899A4 (de) 2004-11-17
WO2002076505A1 (fr) 2002-10-03
US20060058394A1 (en) 2006-03-16
DE60214987D1 (de) 2006-11-09
EP1374899A1 (de) 2004-01-02
US20040122100A1 (en) 2004-06-24
JPWO2002076505A1 (ja) 2004-07-15
CA2440710C (en) 2009-08-18
EP1374899A8 (de) 2004-03-10
DE60214987T2 (de) 2007-09-06
CA2440710A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
BR9917007A (pt) Moduladores de ccr5
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
BR0311867A (pt) Forma de ministração adesiva a mucosa em forma de pelìcula e uso de um extrato ou de um óleo de cannabis para a produção de uma forma de ministração adesiva a mucosa em forma de pelìcula
BRPI0210335B8 (pt) copolímero de blocos, e, composição
EE200300536A (et) Farmatseutiliselt aktiivsed uridiiniestrid
NO20033918L (no) Ny anvendelse av peptidklasse av forbindelser for behandling av allodyni eller andre typer av kronisk smerte eller fantomsmerte
CL2008003391A1 (es) Compuestos derivados de pirrolidinas, moduladores de la funcion del receptor de androgeno (divisional de la solicitud 970-03).
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
NO20052474L (no) Amort form av esomeprazolsalter
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ATE382057T1 (de) Stabile formulierung von modifiziertem glp-1
TNSN06439A1 (fr) Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ATE328995T1 (de) Kontrolliertes wirkstoffabgabesystem
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
BRPI0414581A (pt) derivados de benzimidazol: preparação e aplicações farmacêuticas
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
DK1158959T3 (da) Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler
RS50814B (sr) Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
ATE530197T1 (de) Medizinische zusammensetzungen zur angiogenese- therapie
BR9808895A (pt) Partìcula de detergente
DE60043587D1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
SE9903759D0 (sv) Pharmaceutically active compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties